Medical Devices Investors & VC Firms in United States
516 firms in this list, with a median first check of $500K. 35 of them lead rounds. Generated from verified public data and updated continuously.
CTI Life Sciences Fund L.P.
MontrealSeed–Late Stage
6 people
DEEPCORE Inc.
TokyoSeed–Growth
6 people
Esplanade Ventures
WestmountSeed–Series A
6 people
Foundation Venture Capital Group, LLC
PrincetonPre-Seed–Series A$500K
6 people
Illinois Ventures
ChicagoPre-Seed–Late Stage
6 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage
6 people
Innovation Partnerships at the University of Michigan
Ann ArborSeed–Series A$100K – $300K
3 people
Innovation Works
PittsburghPre-Seed–Series A$100K – $300K
3 people
IT-Farm Corporation
TokyoSeed–Series A
6 people
Latterell Venture Partners
San RamonSeed–Series A$50K – $10M
3 people
Lewis & Clark Ventures
St. LouisSeed–Series A$2M – $7M
3 people
Marram Ventures
ChicagoSeed–Growth
Mass General Brigham Ventures
SomervilleSeed–Series A
6 people
Medical Incubator Japan K.K.
TokyoSeries A–Series B
6 people
NYU Innovation Venture Fund
New YorkPre-Seed–Series A$100K – $500K
3 people
Origin Partners
HillsboroughSeed–Series A$3M – $5M
3 people
Originate Ventures
BethlehemSeed–Series A$500K – $4M
3 people
OSF Ventures
PeoriaSeed–Series A
6 people
Proton Enterprises
Seed–Series A
Quan Capital
Grand CaymanSeed–Late Stage
6 people
Redmont Capital
BirminghamGrowth$1M – $10M
3 people
Rex Health Ventures
RaleighSeed–Series B$250K – $500K
3 people
Scion Life Sciences
New YorkSeed–Late Stage
6 people
Seido Capital
BrusselsPre-Seed–Series B$270K – $2.7M
3 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.